Li et al., 2017 - Google Patents

AIEgen-functionalized mesoporous silica gated by cyclodextrin-modified CuS for cell imaging and chemo-photothermal cancer therapy

Li et al., 2017

Document ID
4975477542430470359
Author
Li Q
Wang D
Cui Y
Fan Z
Ren L
Li D
Yu J
Publication year
Publication venue
ACS applied materials & interfaces

External Links

Snippet

A novel multifunctional drug delivery system has been constructed by assembling per-6-thio- β-cyclodextrin-modified ultrasmall CuS nanoparticles (CD-CuS) onto fluorescent AIEgen- containing mesoporous silica nanoparticles (FMSN). The CD-CuS nanoparticles are …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48961—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANO-TECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
    • B82Y30/00—Nano-technology for materials or surface science, e.g. nano-composites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Similar Documents

Publication Publication Date Title
Li et al. AIEgen-functionalized mesoporous silica gated by cyclodextrin-modified CuS for cell imaging and chemo-photothermal cancer therapy
Anwar et al. Recent advances in synthesis, optical properties, and biomedical applications of carbon dots
Sun et al. Second near-infrared conjugated polymer nanoparticles for photoacoustic imaging and photothermal therapy
Kashyap et al. Smart nanomaterials in cancer theranostics: challenges and opportunities
Rafique et al. Recent advances of upconversion nanoparticles in theranostics and bioimaging applications
Feng et al. A versatile near infrared light triggered dual-photosensitizer for synchronous bioimaging and photodynamic therapy
Scialabba et al. Highly homogeneous biotinylated carbon nanodots: red-emitting nanoheaters as theranostic agents toward precision cancer medicine
Zhang et al. Multifunctional carbon-based nanomaterials: applications in biomolecular imaging and therapy
Bao et al. Hyperthemia-promoted cytosolic and nuclear delivery of copper/carbon quantum dot-crosslinked nanosheets: multimodal imaging-guided photothermal cancer therapy
Ross et al. The analytical and biomedical applications of carbon dots and their future theranostic potential: A review
Mei et al. Progress and trends in AIE-based bioprobes: a brief overview
Fernandes et al. Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives
Lv et al. In situ growth strategy to integrate up-conversion nanoparticles with ultrasmall CuS for photothermal theranostics
Li et al. PEGylated copper nanowires as a novel photothermal therapy agent
Wu et al. Nanoprobes with aggregation-induced emission for theranostics
Guo et al. Boron quantum dots for photoacoustic imaging-guided photothermal therapy
Nguyen et al. Engineered hybrid nanoparticles for on-demand diagnostics and therapeutics
Muhr et al. Upconversion nanoparticles: from hydrophobic to hydrophilic surfaces
Sun et al. Aggregation-induced emission nanoparticles encapsulated with PEGylated nano graphene oxide and their applications in two-photon fluorescence bioimaging and photodynamic therapy in vitro and in vivo
Kim et al. pH-Responsive NIR-absorbing fluorescent polydopamine with hyaluronic acid for dual targeting and synergistic effects of photothermal and chemotherapy
Ostadhossein et al. Functional carbon nanodots for multiscale imaging and therapy
Wang et al. Preparation of novel fluorescent nanocomposites based on Au nanoclusters and their application in targeted detection of cancer cells
Singh et al. Label-free fluorescent mesoporous bioglass for drug delivery, optical triple-mode imaging, and photothermal/photodynamic synergistic cancer therapy
Zhang et al. Supramolecular hybrids of AIEgen with carbon dots for noninvasive long-term bioimaging
Shi et al. Near-infrared light-harvesting fullerene-based nanoparticles for promoted synergetic tumor phototheranostics